Provides detailed analysis of bioengineered
skin substitute products
has provided a proof-of-concept for bioengineered
organ replacement as the next step for regenerative therapy.
The Center also wants to see GMO foods labeled and wants an environmental review before bioengineered
crops are planted.
The investigators performed histologic examinations of wound sites 2 to 6 weeks after placement of Graftskin (Organogenesis, Canton, MA), a bioengineered
skin composed of bovine collagen, viable dermal fibroblasts, and viable keratinocytes.
Because FDA considers most GM foods to be substantially equivalent to their conventional counterparts, the agency again declined to require bioengineered
products to undergo the same extensive premarket approval process required for food additives, or to require bioengineered
products to be labeled.
Under current FDA policy, developers of bioengineered
foods are expected to consult with the agency before marketing their products, so that all safety and regulatory questions can be addressed fully.
tomatoes survive the trip to market better.
a medical device company based in Rockland, Massachusetts, has pioneered and is commercializing minimally invasive diagnostic and therapeutic products based on its proprietary bioengineered
18, 2014 /PRNewswire/ -- This BCC Research report explores the present and future strategies within the bioengineered
protein drugs market.
Pollen wafting from bioengineered
corn to traditional varieties may be undermining the fight to keep pests from evolving resistance to pesticides, according to a new study.
Scientists in the United States and Taiwan have successfully transplanted bioengineered
corneal stem cells to restore or improve vision in patients whose corneas had been damaged by disease or injury.
NASDAQ: BSMD), the medical device company that pioneered the use of bioengineered
microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a procedure called embolization, announced today that it plans to issue financial results for the fourth quarter and year ended December 31, 2006 on January 31, 2007 before the market opens.
Global Markets for Bioengineered
Protein Drugs http://www.
American Oriental Bioengineering (NYSE: AOB) develops, manufactures and markets bioengineered
and traditional Chinese medicinal (TCM) products, primarily in China.
NASDAQ: BSMD) ("BioSphere"), a medical device company that pioneered the use of bioengineered
microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations, today provided an update on physician reimbursement for the uterine fibroid embolization procedure (UFE).